HOXA5 and breast cancer: In a large, independent population of patients with lymph node-negative invasive breast cancer not treated with chemotherapy, we were able to validate reported associations of MGI+HOX13:IL17BR and BCI with breast cancer death among ER-positive patients treated with tamoxifen.